Moderna Advances U.K. Vaccine Plant After Government Deal
Moderna Advances U.K. Vaccine Plant After Government Deal
GALWAY, IRELAND--January 16, 2023--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Moderna Incorporated (NASDAQ:MRNA) (Cambridge, Massachusetts) looks set to move forward with plans to build a new messenger RNA (mRNA) vaccine manufacturing center in the U.K. following a deal with the government.
Within this article: Details new plant for mRNA vaccines in U.K., 10-year deal with government, timelines, investment, capacity
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
